Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.4K Buy
1,152
+225
+24% +$11.9K 0.01% 360
2026
Q1
$51.2K Hold
927
0.01% 368
2025
Q4
$45.5K Hold
927
0.01% 379
2025
Q3
$40K Hold
927
﹤0.01% 406
2025
Q2
$35.6K Buy
927
+260
+39% +$9.94K ﹤0.01% 425
2025
Q1
$25.8K Buy
667
+460
+222% +$16.8K ﹤0.01% 468
2024
Q4
$7K Hold
207
﹤0.01% 640
2024
Q3
$8.46K Sell
207
-400
-66% -$16.4K ﹤0.01% 585
2024
Q2
$23.4K Buy
607
+189
+45% +$7.95K ﹤0.01% 432
2024
Q1
$17.9K Hold
418
﹤0.01% 431
2023
Q4
$15.5K Sell
418
-47
-10% -$1.69K ﹤0.01% 446
2023
Q3
$16.9K Hold
465
﹤0.01% 430
2023
Q2
$16.6K Sell
465
-21
-4% -$753 ﹤0.01% 448
2023
Q1
$17.3K Sell
486
-101
-17% -$3.53K ﹤0.01% 436
2022
Q4
$20.6K Sell
587
-103
-15% -$3.43K ﹤0.01% 357
2022
Q3
$20K Sell
690
-532
-44% -$20.2K 0.01% 346
2022
Q2
$66K Buy
1,222
+335
+38% +$18.5K 0.02% 243
2022
Q1
$48K Hold
887
0.01% 312
2021
Q4
$49K Hold
887
0.01% 312
2021
Q3
$42K Hold
887
0.01% 316
2021
Q2
$44K Hold
887
0.01% 316
2021
Q1
$40K Hold
887
0.01% 309
2020
Q4
$41K Hold
887
0.01% 281
2020
Q3
$42K Hold
887
0.02% 242
2020
Q2
$45K Hold
887
0.02% 235
2020
Q1
$42K Buy
+887
New +$47.3K 0.02% 222

Other funds holding GSK

HHM Wealth Advisors's GSK Position: Q2 2026 in Review

HHM Wealth Advisors increased its GSK (GSK) stake by 24% in Q2 2026, buying an estimated $11.9K and bringing the position to 1,152 shares worth $60.4K. The position accounts for 0.01% of the portfolio, ranked #360.

HHM Wealth Advisors first reported a position in GSK in Q1 2020 and has held it in 26 quarters since. The position peaked at $66K in Q2 2022. 331 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • HHM Wealth Advisors held 1,152 shares of GSK worth $60.4K as of Q2 2026.
  • HHM Wealth Advisors bought 225 GSK shares in Q2 2026, an estimated $11.9K.
  • GSK made up 0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #360 holding.
  • HHM Wealth Advisors first reported a position in GSK in Q1 2020 and has held it in 26 quarters since.
  • HHM Wealth Advisors's GSK position peaked at $66K in Q2 2022.
  • 331 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.